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ABSTRACT: Ferulic acid derivative 012 (FAD012) is a ferulic
acid (FA) derivative. The current study prepared a solid dispersion
of FAD012 and γ-cyclodextrin (γCD) and ground it using a three-
dimensional ball mill (3DGM) to prepare an inclusion complex.
This study also assessed the physicochemical properties such as
solubility of that complex. A Job’s plot indicated that FAD012 and
γCD formed an inclusion complex at a molar ratio of 1:1. Phase
solubility diagrams revealed that FAD012 produced a BS diagram.
According to PXRD, FAD012 produced a diffraction peak at 2θ =
7.0° and γCD produced a diffraction peak at 2θ = 9.1°. Those two
peaks were not produced by the 3DGM, but new peaks (2θ = 7.3
and 16.5°) were evident. DSC patterns revealed an endothermic
peak due to the melting of FAD012 at 190 °C, but no endothermic peaks were evident with the 3DGM. NIR spectra of the 3DGM
indicated that the methyl group of FAD012 produced a higher peak and that the OH groups of γCD produced a higher peak. 1H-1H
ROESY NMR spectra (D2O) revealed cross peaks for protons of the methyl group of FAD012 and a proton (H-3) in the cavity of
γCD, so FAD012 presumably interacts with the wide opening of the γCD torus. A solubility test (25 °C) indicated that solubility
improved about 5-fold for the 3DGM in comparison to the solubility of FAD012 alone (about 140 μg/mL). Based on these findings,
an FAD012/γCD complex was formed by cogrinding, and its solubility improved. These observations are expected to expand the
usefulness of cogrinding of FAD012 with γCD using a 3D ball mill.
■ INTRODUCTION
Cerebrovascular disorders include intracerebral hemorrhage,
subarachnoid hemorrhage, and cerebral infarction. Cerebral
infarction is the most serious of those conditions because it
accounts for most deaths. Drug therapies for cerebral infarction
include intravenous thrombolysis (tissue plasminogen activator
(t-PA) therapy), neuroprotective therapy, and antiplatelet
therapy. However, only certain patients can receive drug
therapy because it must be received within 4.5 h of onset, and
drugs can cause adverse reactions such as bleeding and kidney
damage, so existing drug therapies have disadvantages. A study
some years ago examined the neuroprotective action of ferulic
acid (FA), a natural antioxidant.1
FA is a hydroxycinnamic acid prepared from rice bran. FA
has a high antioxidant capacity2 and ultraviolet-absorbing
action, which is why it is used as a sunscreen,3 as a food
additive to prevent lipid peroxidation,4 and as a supplement
with brain-boosting action.1 However, FA is water-soluble,
which is why it has difficulty reaching the brain. For reference,
the solubility of FA is reported as 780 μg/mL.5 Thus, FA was
molecularly engineered to produce FA derivative 012
(FAD012) with increased fat solubility and improved ability
to traverse the central nervous system.6 FAD012 has a
chemical structure where a methyl group is substituted for
the methoxy group in the aromatic ring of FA, and FAD012 is
more highly fat-soluble and poorly soluble in water than FA, so
FAD012 presumably has drawbacks limiting its full efficacy.
Our research group has already succeeded in synthesizing FA
derivatives other than FAD012 and is finding pharmacological
effects on cerebral circulation.7 Among them, FAD012 is a
compound that is of interest for its pharmacological effects, but
in view of its administration to animals, its solubility is poor;
then, it is thought that a pharmaceutical approach is necessary.
Accordingly, if the solubility of FAD012 could be improved
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and a preparation retaining the antioxidative action could be
devised, then FAD012 might serve as an active pharmaceutical
ingredient that would be efficacious in treating cerebral
infarction.
A cyclic polysaccharide, cyclodextrin (CD), has glucose
pyranose units linked with α-1,4-glucosidic bonds. CD with six
glucose pyranose units is known as αCD, CD with seven such
units is known as βCD, and CD with eight such units is known
as γCD. The exterior of the ring of CD is hydrophilic while the
inside of the cavity is hydrophobic, so various hydrophobic
guest molecules are included in the cavity as a result of
hydrophobic interaction, leading to the formation of inclusion
complexes.8 γCD is an easily digestible water-soluble
substance, and its acceptable daily intake is “not specified”
according to the Joint FAO/WHO Expert Committee on Food
Additives, meaning γCD has very low toxicity. Various
methods have been used to prepare inclusion complexes,
such as coprecipitation,9 kneading,10 freeze-drying,11 and
cogrinding.12 Cogrinding involves applying mechanical energy
in the form of friction, grinding, etc., to a solid substance and
changing its physicochemical properties; this mechanochem-
ical technique forms inclusion complexes without needing a
solvent.13 The current authors previously used cogrinding to
form caffeic acid (CA) and CD inclusion complexes, improving
the elution of CA and retaining its antioxidant capacity.14 FA is
known to form inclusion complexes with CDs.15,16 The
physicochemical evaluation of the complex and the molecular
interaction between FA and CDs in the inclusion state have
been reported.17,18 In other words, since FA forms a complex
with CD, in this study, we attempted to prepare an inclusion
complex with γCD using FAD012.
Cogrinding techniques include the use of a rod mill, ball
mill, or jet mill. CA/γCD inclusion complexes have been
prepared by grinding with a rod mill,19 foods and teas have
been pulverized with a ball mill,20 and a jet mill has been used
to grind bulk pharmaceuticals.21 Over the past few years,
cogrinding using a three-dimensional (3D) ball mill has been
developed as a new grinding technique. A 3D ball mill has a
vertical and a horizontal axis of rotation, and it uses the entire
inner surface of a spherical container, limiting the heat of
friction and uneven mixing, which are drawbacks of a two-
dimensional ball mill. A 3D ball mill allows highly uninform
grinding and mixing in a short period of time.22 The current
authors previously used a 3D ball mill to grind daidzein, a
soybean constituent, to form a daidzein/γCD complex, thus
improving the solubility of daidzein.23 Accordingly, if an
FAD012/γCD complex (Scheme 1) could be prepared with a
new cogrinding technique using a 3D ball mill, then the
functionality of FAD012 should be retained and its solubility
should improve. If the FAD012/γCD complex could be
prepared by a 3D ball mill, it could be proposed as a novel
preparation method. Furthermore, if the physicochemical
properties of the FAD012/γCD complex can be elucidated
and γCD contributes to solubility improvement as an additive,
the dosage form will be changed from an oral formulation to a
parenteral formulation such as an injection or an ointment, and
it can be considered as a research result that is the basis for
expanding the administration routes such as mucosal and
transdermal absorption.
Thus, the current study used a 3D ball mill to grind a
mixture of FAD012 and γCD in order to prepare an inclusion
complex, and this study assessed the physicochemical proper-
ties such as solubility of that complex.
■ RESULTS AND DISCUSSION
Determination of Complexation Stoichiometry. A
Job’s plot was prepared in order to determine the ratio of
FAD012 and γCD in a complex. Job’s method (the method of
continuous variation)24 is a method of determining the ratio of
components in a complex based on the additive nature of
changes in absorbance due to changes in physical properties
during complex formation. A plot of the changes in the
absorbance of FAD012 when γCD was added is shown in
Figure 1. The addition of γCD resulted in the largest changes
in absorbance when the ratio of FAD012/γCD was 0.5 (result
of the approximate curve equation: y = −0.0933x2 + 0.0882x −
0.005 (x ≈ 0.472), so in solution, the ratio of FAD012 and
γCD in the complex is presumably 1:1.25 Since the Job’s plot
indicated that the molar ratio of FAD012/γCD was 1:1, the
current study used a 3D ball mill to prepare a mixture at that
molar ratio, and this study assessed the physicochemical
properties of that complex.
Phase Solubility Studies. Phase solubility diagrams were
prepared in order to determine the molar ratio and stability
constant for the FAD012/γCD inclusion complex. After
shaking for 24 h, the solubility of intact FAD012 was 116
μg/mL. Phase solubility diagrams indicated that the solubility
of FAD012 increased as the concentration of γCD increased.
At high concentrations of CD, the concentration of FAD012
decreased due to the precipitation of a solid complex,
producing a BS diagram according to the classification of
Higuchi and Connors (Figure 2). Rodrigues Sa ́ Couto et al.
Scheme 1. Proposed Structural Images of FAD012/γCD
Complexes
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reported that carbamazepine /γCD produced a BS diagram.
26
When the stability constant (Ks) was calculated using eq 1, the
stability constant for FAD012 was 782.9 M−1. When the
complexation efficiency (CE) was calculated using eq 2, it was
0.62. In addition, the slope of the phase solubility diagram was
smaller than 1.0, so FAD012 and γCD presumably form an
inclusion complex at a molar ratio of 1:1.
PXRD. Job’s plot and phase solubility diagrams suggested
that in an aqueous solution, FAD012 is included in γCD at a
molar ratio of 1:1. Formation of a complex between an
inorganic compound and an organic compound or a complex
between organic compounds causes a change in the crystal
structure of the drug. Therefore, powder X-ray diffraction
(PXRD) measurement is useful for confirming changes in the
crystal structure in the solid state.27 Thus, PXRD was
performed in order to examine the crystalline state of the
3DGM (FAD012/γCD) prepared by cogrinding using a 3D
ball mill. Intact FAD012 produced characteristic diffraction
peaks due to FAD012 at 2θ = 7.0 and 11.5°, and γCD
produced a characteristic diffraction peak due to γCD at 2θ =
9.1° (Figure 3a, b). The physical mixture (PM) (FAD012/
γCD = 1:1) produced a diffraction peak due to FAD012 at 2θ
= 7.2° and a diffraction peak due to γCD at 2θ = 9.1° (Figure
3c). With the 3DGM with water (3DGMw) (FAD012/γCD =
1:1), the diffraction peak due to FAD012 disappeared and a
new diffraction peak was produced at 2θ = 16.5° (Figure 3d).
The 3DGM with no water (3DGMnw) produced diffraction
peaks due to FAD012 at 2θ = 6.9 and 11.5° and a diffraction
peak due to γCD at 2θ = 8.8° (Figure 3e).
These findings suggest that an FAD012/γCD complex was
formed in the 3DGMw, which was prepared using a 3D ball
mill and which had water added. A study used a 3D ball mill to
prepare a ground mixture of daidzein/γCD, and it reported the
usefulness of that 3D ball mill.23 When a substance is ground
using a 3D ball mill without adding distilled water, it is not
sufficiently dispersed and mixed, so it is not readily included.
When a substance is ground using a 3D ball mill and distilled
water is added, however, moisture is removed from γCD, so
FAD012 is presumably able to readily enter the cavity of γCD
to form an inclusion complex.
DSC. PXRD patterns suggested that an inclusion complex
was formed in the 3DGMw (FAD012/γCD). A study has
reported that changes in the thermal behavior are evident
when formation of an inclusion complex causes a disappear-
ance or shifting of the melting point of the guest molecule.28
Thus, DSC was performed in order to examine the thermal
behavior of the 3DGMw (FAD012/γCD) prepared using a 3D
ball mill. DSC patterns indicated that intact FAD012 produced
an endothermic peak due to melting at around 200 °C (Figure
4a). The PM (FAD012/γCD) produced an endothermic peak
due to the melting of FAD012 at around 190 °C, so crystals of
FAD012 are presumably present (Figure 4c). With the
3DGMw (FAD012/γCD), the endothermic peak due to
FAD012 disappeared (Figure 4d). These findings indicate
that an inclusion complex is formed in the 3DGMw (FAD012/
γCD), causing FAD012 to be included in the cavity of γCD.
This presumably explains the disappearance of the endother-
mic peak due to FAD012.
FT-IR Spectroscopy. DSC and PXRD patterns suggested
that an inclusion complex may be formed in the 3DGMw
(FAD012/γCD). IR measurement is a useful technique for
collecting information for understanding intramolecular
interactions and intermolecular interactions of drugs. In
particular, when a hydrogen bond or the like contributes as
an intermolecular interaction between drugs, a peak shift of a
functional group such as a hydroxyl group or a carbonyl group
Figure 1. Job’s plot of the FAD012/γCD systems. Results were
expressed as mean ± SD (n = 3).
Figure 2. Phase solubility diagrams of FAD012/γCD. Results were
expressed as mean ± SD (n = 3).
Figure 3. PXRD patterns of FAD012/γCD:(a) intact FAD012, (b)
intact γCD, (c) PM (FAD012/γCD = 1:1), (d) 3DGMw (FAD012/
γCD = 1:1), and (e) 3DGMnw (FAD012/γCD = 1:1).
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occurs.29,30 Thus, FT-IR spectroscopy was performed in order
to examine the molecular state of the complex in the solid
state. Intact FAD012 produced a peak due to the aromatic ring
(benzene ring) at 1600 cm−1, a peak due to the carbonyl group
at 1653 cm−1, a peak due to the alkyl groups at 2566−3023
cm−1, and a peak due to hydroxyl groups at 3378 cm−1 (Figure
5a). Intact γCD produced a peak due to hydroxyl groups at
3366 cm−1 (Figure 5b). With the 3DGMw (FAD012/γCD),
the aromatic ring (benzene ring) in FAD012 produced a lower
peak at 1598 cm−1, the carbonyl group produced a higher peak
at 1680 cm−1, alkyl groups produced a lower peak at 2919
cm−1, and hydroxyl groups produced a lower peak at 3345
cm−1 (Figure 5d) in comparison to intact FAD012. Higashi et
al. reported that hydrogen bonds between molecules with a
dimeric structure dissociated as a result of complex formation,
producing a higher peak due to a carbonyl group.31 These
findings presumably indicate that the FAD012 dimer in the
3DGMw (FAD012/γCD) dissociated in the solid state and
that dissociated FAD012 presumably interacted with the cavity
of γCD via hydrogen bonds. In other words, FAD012
presumably enters the cavity of γCD, forming an inclusion
complex.
NIR Spectroscopy. FT-IR spectra of the 3DGMw
(FAD012/γCD) presumably indicated molecular interaction
between the hydroxyl groups of FAD012 and γCD and the
alkyl group of FAD012 in the solid state. However, the FT-IR
spectra were not able to attribute that interaction to hydroxyl
groups or the alkyl group. Thus, NIR spectroscopy was
performed with a focus on the hydroxyl groups and the alkyl
group. Intact FAD012 produced peaks due to C−H bonds in
the aromatic ring (benzene ring) in FAD012 at 4388 and 8684
cm−1, and it produced peaks due to the alkyl group at 4320 and
8356 cm−1 (Figure 6bX,Z). In addition, γCD produced a peak
due to its hydroxyl groups at 4772 cm−1 and a peak due to
moisture at 5240 cm−1 (Figure 6bY). With the 3DGMw
(FAD012/γCD), the peaks due to the C−H bonds in the
benzene ring of FAD012 shifted to 4412 and 8652 cm−1, and
the peaks due to the alkyl group shifted to 4356 and 8348 cm−1
in comparison to intact FAD012. In addition, the hydroxyl
groups of γCD produced a higher peak at 4796 cm−1, and the
peak due to moisture in γCD broadened. When peaks in the
NIR spectra broaden or shift, the functional groups of drugs
are interacting.32 These findings for the 3DGMw (FAD012/
γCD) presumably indicate molecular interaction in the solid
state due to the cavity of γCD and hydrogen bonds with
FAD012.
SEM. DSC and PXRD patterns suggested that a complex is
formed in the 3DGMw (FAD012/γCD). SEM and TEM
observations are useful as methods for confirming the drug
shape. Then, combined with information such as SEM and
XRD, it is possible to consider the characteristics of such a
complex.33 In addition, PXRD patterns indicated that the
crystalline state of the complex changes. Thus, SEM was
performed in order to observe the shape and surface of crystals.
FA012 crystals were smooth needles of about 500 μm in size
(Figure 7a). γCD crystals were angular with a smooth surface,
and particles were about 50 μm in size (Figure 7b). Changes in
the surface of particles were not noted in the PM (FAD012/
γCD) (Figure 7c). In the 3DGMw (FAD012/γCD), particles
were about 300 μm in size, and angular crystals with a smooth
surface were evident (Figure 7d). Typically, an inclusion
complex with γCD is cubical.34 The current study similarly
found cubical crystals in the 3DGMw (FAD012/γCD),
suggesting that FAD012 and γCD may form an inclusion
complex in the solid state.
Measurement of 1H-1H ROESY NMR Spectra. 1H-1H
ROESY NMR spectroscopy was performed in order to
examine the detailed molecular interaction in the 3DGMw
(FAD012/γCD) in solution. 1H-1H ROESY NMR spectros-
copy can reveal interaction between a guest molecule and the
cavity of CD, so it is used to estimate the relative position of
the inclusion complex. With the 3DGMw (FAD012/γCD),
there was a cross peak between H-3 (3.7 ppm) inside the
cavity of γCD and H-b (6.6 ppm), H-c (7.1 ppm), and H-d
(2.0 ppm) of FAD012 (Figure 8a). In addition, there was a
cross peak between H-5 (3.6 ppm) inside the cavity of γCD
and H-a (2.0 ppm), H-b (6.6 ppm), and H-c (7.1 ppm) of
FAD012 (Figure 8b). Typically, H-3 is a proton in the wide
aperture of the CD ring while H-6 is a proton in the narrow
aperture of the CD ring.35 These findings presumably indicate
that the carbonyl group in the FAD012 molecule is included in
γCD from the wide to the narrow opening of its torus.
Solubility of FAD012/γCD Systems in Distilled Water.
Assessment of physical properties in the solid state indicated
that an inclusion complex was formed in the 3DGMw
Figure 4. DSC curves of FAD012/γCD systems: (a) intact FAD012,
(b) intact γCD, (c) PM (FAD012/γCD = 1:1), and (d) 3DGMw
(FAD012/γCD = 1:1).
Figure 5. FT-IR spectra of FAD012/γCD systems: (a) intact
FAD012, (b) intact γCD, (c) PM (FAD012/γCD = 1:1), and (d)
3DGMw (FAD012/γCD = 1:1).
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(FAD012/γCD) at a molar ratio of 1:1. Thus, a solubility test
was performed in order to determine whether the solubility of
FAD012 improved as a result of molecular interaction between
FAD012 and γCD (Table 1). One hour after the start of the
test, the solubility of intact FAD012 was 134.4 μg/mL while
solubility in the 3DGMw (FAD012/γCD) was 656.7 μg/mL,
indicating that solubility increased about 5-fold. This is
presumably due to molecular interaction as a result of the
formation of an FAD012 and γCD inclusion complex by
cogrinding using a 3D ball mill. In other words, 3DGM has a
high-speed 3D rotation that has achieved noncriticality, and it
is possible to contribute to a new drug formulation research by
enabling a nonaggregated and highly uniform ground mixture.
As a formulation design of FAD012, poorly water-soluble
Figure 6. (a) NIR absorption spectra of FAD012/γCD systems observed at 4000−10,000 cm−1. (b) NIR absorption spectra of FAD012/γCD
systems: (X) second differential near-infrared absorption spectra of FAD012/γCD observed at 8200−8800 cm−1; (Y) second differential near-
infrared absorption spectra of FAD012/γCD observed at 4600−5400 cm−1; (Z) second differential near-infrared absorption spectra of FAD012/
γCD observed at 4000−4600 cm−1.
Figure 7. SEM morphology of FAD012/γCD systems: (a) intact
FAD012, (b) intact γCD, (c) PM (FAD012/γCD = 1:1), and (d)
3DGMw (FAD012/γCD = 1:1).
Figure 8. 1H-1H ROESY NMR spectra of FAD012/γCD systems.
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FAD012 formed an inclusion complex with γCD, and the
solubility was improved by changing the dosage form from an
oral preparation to a parenteral injection or ointment; it can
contribute to the expansion of administration routes such as
transdermal absorption. In the future, it is necessary to conduct
in vivo tests for the purpose of using FAD012.
■ CONCLUSIONS
The current study prepared an FAD012/γCD inclusion
complex by cogrinding using a 3D ball mill unlike the
previously reported methods. In the 3DGMw (FAD012/γCD),
the carbonyl group of the FAD012 molecule was included in
γCD. The 3DGMw (FAD012/γCD) had improved solubility,
which was found to have contributed to the formation of an
inclusion complex. Based on these results, cogrinding using a
3D ball mill should be useful and the use of FAD012 is
expected to expand.
αCD and βCD have different numbers of bonds. In the
future, differences in forms of inclusion in αCD and βCD need
to be determined.
■ MATERIALS AND METHODS
Materials. FAD012 (Figure 9a) was purified by the Josai
University Pharmaceutical Chemistry Laboratory. γCD (Figure
9b) was provided by Cyclo Chem Co., Ltd. (Tokyo, Japan)
and was stored at a temperature of 40 °C and 82% relative
humidity for 7 days. 2,2-Diphenyl-1-picrylhydrazyl was
obtained from Sigma-Aldrich. Other chemicals were of special
grade and were purchased from Fujifilm Wako Pure Chemical
Corporation, Tokyo.
Preparation of a Physical Mixture and a Ground
Mixture. The physical mixture (PM) was prepared by mixing
FAD012 and γCD at a molar ratio of 1:1 using a vortex mixer
for 1 min. The ground mixture (3DGM) of FAD012 and γCD
was prepared by grinding the PM (FAD012/γCD) (500 mg
total) using a 3D ball mill with a 200 g ball of Φ5 mm for 60
min, and 300 μL of water was added (3DGMw) or not
(3DGMnw).
Methods. Determination of Complexation Stoichiom-
etry. The molar ratio of inclusion of FAD012 and γCD was
determined according to Job’s method (the method of
continuous variation).24 The ratio of FAD012/γCD concen-
trations was changed from 0.1 to 0.9, and the change in
absorbance was plotted. After the test solution reached
equilibrium, the sample was filtered with a 0.45 μm membrane
filter. Absorbance was measured at a wavelength of 308 nm
using an ultraviolet visible spectral photometer (UV-2500PC,
Shimadzu Corporation).
Phase Solubility Study. Phase solubility studies were
performed according to the method of Higuchi and Connors.36
A supersaturated amount of FAD012 was added to an aqueous
solution (10 mL) with a concentration of γCD (0−35 mM). A
suspension was obtained via shaking for 24 h (25 ± 0.5 °C) at
100 rpm using a constant temperature shaker (BR42FL, Taitec
Co., Ltd.). Once the suspension reached equilibrium, it was
filtered through a 0.45 μm membrane filter (hydrophilic
poly(tetrafluoroethylene) filter, DISMIC), and the solution
was quantified. The apparent stability constant (Ks) of the
FAD012/γCD complex was calculated using eq 1 based on the
slope of the solubility phase diagram and the solubility (S0) of
FAD012 in the absence of γCD.
=
−
K
S
slope
(1 slope)s 0 (1)
= × = −S KCE slope/(1 slope)0 s (2)
Quantitative of FAD012 with HPLC. Solubility was
quantified using a high-performance liquid chromatograph
(HPLC: LC-20ADvp, Shimadzu Corporation) at a wavelength
of 308 nm. The column used was a Cosmosil 5C18-AR-II
packed column (4.6 mm, I.D. × 150 mm), the sample injection
volume was 50 μL, and the column temperature was 40 °C.
The mobile phase for FAD012 consisted of water/methanol/
phosphoric acid (60:39:1), and the retention time of FAD012
was 11 min. In the UV spectrum measurement, the absorbance
of FAD012 showed a characteristic absorption maximum at
308 nm (data not shown). Therefore, the UV wavelength was
set at 308 nm during the HPLC measurement.
Powder X-Ray Diffraction (PXRD). The diffraction intensity
was measured with a NaI scintillation counter using a Miniflex
II powder X-ray diffractometer (Rigaku Corporation, Tokyo).
Cu rays (30 kV, 15 mA) were used as X-rays, the scanning rate
Table 1. Solubility of FAD012/γCD Systems in Distilled Water (25 ± 0.5 °C)a
solubility (μg/mL)
sample 1 h 3 h 6 h 24 h
FAD012 intact 134.4 ± 43.9 151.3 ± 65.1 152.8 ± 60.7 149.7 ± 57.0
3DGMw (FAD012/γCD) 656.7 ± 19.7 753.7 ± 6.1 854.7 ± 85.7 840.2 ± 77.3
aResults were expressed as mean ± SD (n = 3).
Figure 9. Chemical structures of (a) FAD012 and (b) γCD.
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for measurement of X-ray diffraction was 4°/min, and the
measurement range was 2θ = 5−30°. Measurement was
performed by placing a powder sample onto a glass plate so
that the surface of the sample was flat.
Differential Scanning Calorimetry (DSC). The Themo plus
Evo high-sensitivity differential scanning calorimeter (Rigaku
Corporation, Tokyo) was used to perform DSC. Calorimetry
was performed by placing about 2 mg of the sample in an
aluminum sealed pan and subjecting it to a nitrogen gas stream
(60 mL/min) with temperature rising at a rate of 5.0 °C.
Fourier Transform Infrared Spectroscopy (FT-IR). Spec-
troscopy was performed with the JASCO FT/IR-410 (JASCO
Corporation) using the KBr tablet method. The number of
integrations was 32, the resolution was 4 cm−1, and the
measurement wavenumber range was 400−4000 cm−1. A tablet
was prepared by adding potassium bromide (KBr) to the
sample at a weight ratio of 1:10 (sample/KBr), mixing, and
manual pressing. Background correction was performed using
KBr single tableting.
Near-Infrared (NIR) Absorption Spectroscopy. A Fourier
transformed near-infrared analyzer (Buchi NIR Flex N-500:
Nihon Buchi) was used to perform NIR absorption spectros-
copy. Conditions used were a measuring wavenumber of
10,000−4000 cm−1, a measurement time of 8 s, and a
measuring temperature of 25 °C. Each sample was filled into a
sample cup and measured with an optical path length of 1 nm.
Scanning Electron Microscopy (SEM). SEM was performed
using a S3000 N scanning electron microscope (Hitachi High-
Technologies Corporation). Each sample was subjected to
gold deposition for 60 s and observed under a pressure voltage
of 10 kV.
Measurement of 1H-1H Rotating-Frame Overhauser Effect
Spectroscopy (ROESY) NMR Spectra. 1H-1H ROESY NMR
spectra were obtained using the NMR System 700 MHz
(Agilent Technologies). Conditions used were D2O as a
solvent, a resonance frequency of 699.6 MHz, 256 increments,
a temperature of 25 °C, a pulse width of 45°, and a relaxation
time of 1.5 s.
Solubility of FAD012/γCD Systems in Distilled Water.
FAD012 (5 or 50 mg) or the 3DGM (FAD012/γCD) was
added to 10 mL of distilled water, and the mixture was shaken
for 1, 3, 6, or 24 h at a temperature of 25 °C. After each round
of shaking, the mixture was filtered with a 0.45 μm membrane
filter. The resulting sample was diluted five times in distilled
water/methanol (3:5) and subjected to HPLC.
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